Christopher Rovaldi - Net Worth and Insider Trading

Christopher Rovaldi Net Worth

The estimated net worth of Christopher Rovaldi is at least $5 Million dollars as of 2024-06-14. Christopher Rovaldi is the SVP, Program Mgmt and Ops of Acceleron Pharma Inc and owns about 25,858 shares of Acceleron Pharma Inc (XLRN) stock worth over $5 Million. Christopher Rovaldi is also the COO of Keros Therapeutics Inc and owns about 0 shares of Keros Therapeutics Inc (KROS) stock worth over $0. Details can be seen in Christopher Rovaldi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Rovaldi has not made any transactions after 2022-04-06 and currently still holds the listed stock(s).

Transaction Summary of Christopher Rovaldi

To

Christopher Rovaldi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Rovaldi owns 2 companies in total, including Acceleron Pharma Inc (XLRN) , and Keros Therapeutics Inc (KROS) .

Click here to see the complete history of Christopher Rovaldi’s form 4 insider trades.

Insider Ownership Summary of Christopher Rovaldi

Ticker Comapny Transaction Date Type of Owner
XLRN Acceleron Pharma Inc 2018-04-03 SVP & Program Mgmt and Ops
KROS Keros Therapeutics Inc 2022-04-06 Chief Operating Officer

Christopher Rovaldi Latest Holdings Summary

Christopher Rovaldi currently owns a total of 2 stocks. Among these stocks, Christopher Rovaldi owns 25,858 shares of Acceleron Pharma Inc (XLRN) as of April 3, 2018, with a value of $5 Million and a weighting of 100%. Christopher Rovaldi also owns 0 shares of Keros Therapeutics Inc (KROS) as of April 6, 2022, with a value of $0 and a weighting of 0%.

Latest Holdings of Christopher Rovaldi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XLRN Acceleron Pharma Inc 2018-04-03 25,858 178.75 4,622,118
KROS Keros Therapeutics Inc 2022-04-06 0 47.83 0

Holding Weightings of Christopher Rovaldi


Christopher Rovaldi Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Rovaldi has made a total of 0 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years. The most-recent trade in Acceleron Pharma Inc is the sale of 3,500 shares on April 3, 2018, which brought Christopher Rovaldi around $134,400.

According to the SEC Form 4 filings, Christopher Rovaldi has made a total of 2 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Keros Therapeutics Inc is the sale of 1,728 shares on April 6, 2022, which brought Christopher Rovaldi around $112,320.

Insider Trading History of Christopher Rovaldi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Rovaldi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Rovaldi Ownership Network

Ownership Network List of Christopher Rovaldi

No Data

Ownership Network Relation of Christopher Rovaldi

Insider Network Chart

Christopher Rovaldi Owned Company Details

What does Acceleron Pharma Inc do?

Who are the key executives at Acceleron Pharma Inc?

Christopher Rovaldi is the SVP & Program Mgmt and Ops of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .

Acceleron Pharma Inc (XLRN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acceleron Pharma Inc Insider Transactions

No Available Data

Christopher Rovaldi Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Rovaldi. You might contact Christopher Rovaldi via mailing address: C/o Acceleron Pharma Inc., 128 Sidney St., Cambridge Ma 02139.

Discussions on Christopher Rovaldi

No discussions yet.